Creative Planning

Position in ABUS — Arbutus Biopharma Corp

CIK 1540235 OVERLAND PARK, KS

Position in ABUS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$298,132

+$27,606 QoQ

Shares Held

62,111

+3.3% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#78

of 175 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Creative Planning holds $452,608,635 across 219 Biotechnology names. ABUS ranks #148 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	127,672	$63,418,511
2	REGN	Regeneron Pharmaceuticals, Inc.	36,949	$23,039,178
3	EXEL	Exelixis, Inc.	270,292	$14,706,586
4	INCY	Incyte Corp	110,664	$12,544,870
5	CYTK	Cytokinetics Inc	141,939	$12,091,783
6	RVMD	Revolution Medicines, Inc.	64,120	$12,008,393
7	ARGX	Argenx SE	12,744	$11,823,500
8	BMRN	Biomarin Pharmaceutical Inc	153,161	$8,763,872

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$298,132	62,111	+3.3%	Shares	Sole	2026-08-13
2026-03-31	$270,526	60,117	+15.8%	Shares	Sole	2026-05-12
2025-12-31	$249,720	51,917	+0.4%	Shares	Sole	2026-02-17
2025-09-30	$234,681	51,692	-2.4%	Shares	Sole	2025-11-14
2025-06-30	$163,578	52,938	-14.7%	Shares	Defined	2025-08-08
2025-03-31	$216,690	62,089	+28.4%	Shares	Sole	2025-05-15
2024-12-31	$158,084	48,344	-2.3%	Shares	Defined	2025-02-14
2024-09-30	$190,574	49,500	+13.8%	Shares	Defined	2024-10-11
2024-06-30	$134,448	43,511	+45.7%	Shares	Sole	2024-08-15
2024-03-31	$77,038	29,860	+105.0%	Shares	Sole	2024-05-13
2023-12-31	$36,415	14,566	-39.8%	Shares	Sole	2024-02-14
2021-03-31	$80,619	24,210	-9.3%	Shares	Sole	2021-04-30
2020-12-31	$94,795	26,703	-18.5%	Shares	Sole	2021-01-29
2020-06-30	$59,601	32,748	—	Shares	Sole	2020-07-23
No filing history on record for this holder in this stock.